Quick Answer
iBio, Inc. reported Gross Profit of $2.17 million for the year ending 2022.
- iBio, Inc. showed an increase of +138.4% in Gross Profit from 2021 to 2022.
- This data is from iBio, Inc.'s annual report (Form 10-K), filed with the SEC on October 11, 2022.
- XBRL data for this metric is available from 2020 to 2022 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $10.0 thousand | Q3 2020: $303.0 thousand | Q4 2020: $494.0 thousand | Q1 2021: $272.0 thousand | Q3 2021: $171.0 thousand | Q4 2021: $55.0 thousand | Q1 2022: $1.90 million.
- Over the full 3 years of available data (2020 to 2022), iBio, Inc.'s Gross Profit has grown by 131.8%.
- Historical annual values: Fiscal year 2022: $2.17 million | Fiscal year 2021: $909.0 thousand | Fiscal year 2020: $935.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: